Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate safety of S.flexneriza-S.sonnei Bivalent Conjugate Vaccine in healthy volunteers aged above 3 Months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03561181
Study type Interventional
Source Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Contact
Status Completed
Phase Phase 1
Start date July 18, 2017
Completion date February 8, 2018

See also
  Status Clinical Trial Phase
Completed NCT02280044 - Efficacy of Rifaximin in Preventing Campylobacteriosis Phase 2/Phase 3
Completed NCT01080716 - Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Phase 1/Phase 2
Completed NCT00490932 - New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Phase 4
Completed NCT01306383 - Solar Disinfection (SODIS) of Drinking Water for Use in Developing Countries or in Emergency Situations N/A
Not yet recruiting NCT01638039 - Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections N/A
Completed NCT04865497 - Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old Phase 2
Recruiting NCT05156528 - Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years Phase 3
Completed NCT01672580 - Social Network Interventions in Rural Honduras N/A